The majority were also receiving drugs for the management of cardiovascular disorders (LEV 69.7 %, standard AEDs 75.5 %) including angiotensin converting enzyme inhibitors, statins and beta-blockers. This evidence concerns the gene ACE and cardiovascular disorder.